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NRXN1The Tar DNA-binding protein 43 (TARDBP, TDP-43) regulates RNA processing and miRNA biogenesis and is
known to be involved in neurodegeneration. Messenger RNA (mRNA) targets of TDP-43 have recently been sys-
tematically identiﬁed, but small RNAs (sRNAs) bound by TDP-43 have not been studied in details. Here, we
reexamine cross-linking, immunoprecipitation and sequencing (CLIP-seq) data, and identify pre-miRNAs,
miRNAs and piRNAs bound by TDP-43 in human and mouse brains. Subsequent analysis of TDP-43 binding
miRNAs suggests that target genes are enriched in functions involving synaptic activities. We further identify a
novel miRNA (miR-NID1) processed from the intron 5 of human neurexin 1,NRXN1, and show thatmiR-NID1 re-
presses NRXN1 expression by binding to TDP-43. Our results are in accordance with previously published data
indicating TDP-43 through binding of speciﬁc miRNAs to play roles in neurodevelopmental activities and neuro-
logical disorders and further our understanding of TDP-43 function.
© 2013 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-ND license. 1. Introduction
MicroRNAs (miRNAs), small interfering RNAs (siRNAs) and Piwi-
interacting RNAs (piRNAs) are three major classes of small RNAs
(sRNAs).miRNAs have beenwidely studied during the past two decades
since theywere discovered [1], and play important roles almost in all bi-
ological processes [2]. Generally, miRNA precursors (pre-miRNAs) arise
from cleavage of long primary miRNAs (pri-miRNAs) by drosha in the
nucleus, while miRNAs are cleaved from the pre-miRNAs by dicer in cy-
toplasm and subsequently incorporated into the RNA-induced silencing
complexes (RISCs) to guide the regulation of speciﬁc target genes [3]. A
major fraction of themiRNA genes is located in introns of protein coding
or noncoding host genes [4]. Coexpression between intronic miRNAs
and their host genes has been demonstrated by microarray proﬁling
[5]. In addition, direct regulation of host genes by their intronic miRNAs
has also been reported [6].
Endogenous siRNAs are generated from double-stranded precur-
sors arising from inverted repeats or bidirectional transcription.
These are cleaved by dicer and loaded into small interfering RISCs
(siRISCs), which in turn degrade targeted mRNAs [7]. The details of
the piRNA biogenesis are not well understood. What is known so farnc. Open access under CC BY-NC-ND liis that piRNA biogenesis consists of a primary piRNA processing path-
way and the ping-pong ampliﬁcation cycle [8].
miRNAs usually base-pair with complementary target sites in 3′ UTR
to repress the expression of target genes. Several computationalmethods
have been developed to predict target genes ofmiRNAs, such asmiRanda
[9], PITA [10] and TargetScan [11]. The miRanda algorithm considers the
stability of the duplex structure formed by miRNA and 3′ UTR region.
PITA focuses on the accessibility of miRNA binding sites on the target
transcripts. TargetScan is able to ﬁnd conserved miRNA-target comple-
mentarity across most vertebrates. These computational methods pro-
vide researchers with a large amount of miRNA–mRNA interaction
candidates, but these predicted candidates include many false positives
due to the diverse mechanisms of miRNA–mRNA interactions. Next gen-
eration sequencing technologies have facilitated the research of genome
and transcriptome. These technologies have been widely used in proﬁl-
ing the expression levels of RNAs and identifying novel non-coding
RNAs, including sRNAs. Several stand-alone software and web servers
have been developed to analyze the high-throughput sequencing data
of miRNAs, such as miRDeep [12] and miRanalyzer [13].
Ubiquitinated TDP-43was ﬁrst detected in proteinaceous inclusions,
and several studies have suggested associations between TDP-43 and
neurodegenerative disorders, including Amyotrophic Lateral Sclerosis
(ALS) and Frontotemporal Lobar Degeneration (FTLD) [14–16]. TDP-43
has an evolutionary conserved structure and preferentially binds to
TG/UG repeats [17,18]. TDP-43 was originally found to repress gene
expression by binding to the promoter region of the gene [19–21].
Further studies have shown that TDP-43 binds to about one third of
human and mouse mRNAs, and regulates their expression and splic-
ing patterns [22,23]. Recent published papers show that TDP-43cense. 
Fig. 1. Enrichment analysis of the target genes of TDP-43 binding miRNAs. A. GO term
enrichment analysis. The most enriched Biological Process, Cellular Component and
Molecular Function GO terms are shown. B. KEGG pathway enrichment analysis. The
20 most enriched KGEE pathways are shown.
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complexes [24–26].
In this study, we identiﬁed binding of pre-miRNAs, miRNAs and
piRNAs by TDP-43 through recently published CLIP-seq data from
human and mouse samples [22,23]. Potential target genes of the
TDP-43 binding miRNAs were computationally predicted, and func-
tional enrichment analysis of the predicted target genes indicated
overrepresentation of functions related to neural activity and neural
diseases. We also identiﬁed a novel miRNA that was transcribed in
several cell and tissue samples from human and which we labeled
NRXN1 intron derived miRNA, miR-NID1. Our results showed that
miR-NID1 was enriched in nuclei, and could bind to TDP-43. Further
analysis showed that the expression level of miR-NID1was negatively
correlated with that of NRXN1 in the human samples, and that
miR-NID1 could repress human NRXN1 expression, possibly through
an association between miR-NID1 and TDP-43.
2. Results
2.1. Transcriptome-wide identiﬁcation of TDP-43 binding sRNAs
Binding RNAs of TDP-43 have been systematically identiﬁed
through cross-linking, immunoprecipitation and high-throughput
sequencing (CLIP-seq or HITS-CLIP) in human and mouse samples
[22,23]. Reads from CLIP-seq of human and mouse samples were
mapped to human (hg19) and mouse (mm10) genomes, respectively,
to obtain the genomic coordinates of binding sites of TDP-43 binding
RNAs. We obtained their CLIP-seq data in BED format. TDP-43 binding
sites in RNAs from human samples were at individual nucleotide
resolution. We found similar TDP-43 binding patterns in NEAT1
as those found by Tollervey et al. [22] (Supplemental Fig. 1). We
extracted genomic coordinates of the TDP-43 binding sites, and
collected genomic coordinates of pre-miRNA, miRNA and piRNA loci
in human and mouse. Comparison of these genomic coordinates
using BEDTools [27] identiﬁed potential TDP-43 binding sites in 455
pre-miRNAs, 320 miRNAs and 2968 piRNAs in human and mouse
(Table 1, Supplemental Tables 1, 2 and 3). Compared with controls,
more pre-miRNAs and miRNAs containing potential TDP-43 binding
sites were found in the brains of Frontotemporal Lobar Degeneration
(FTLD) patients. Associations between miRNAs and human diseases
obtained from the miR2Disease web server [28] showed that some
of these potential TDP-43 binding miRNAs are involved in various pa-
thologies, such as cancers and neurological diseases (Supplemental
Table 4).
2.2. Functional annotations of target genes of TDP-43 binding miRNAs
Sixty-six potential TDP-43 binding miRNAs were found in human,
12 of these being identiﬁed in at least two samples (marked in red in
Supplemental Table 2). To further study the biological functions of the
TDP-43 binding miRNAs, we predicted the mRNA targets of these 12
miRNAs using three different computational methods (miRanda [9],
PITA [10] and TargetScan [11]). This resulted in 1204 potential targetTable 1
sRNAs with potential TDP-43 binding sites.
Organism Homo sapiens
Sample Brain_C Brain_F hES SH-SY
Pre-miRNAs 35 49 108 60
miRNAs 7 13 44 19
piRNAs 37 35 122 66
Reads from TDP-43 CLIP-seq of human and mouse samples were mapped to human and mo
of TDP-43 binding RNAs. Comparison of gene coordinates of human and mouse RNAs and ge
455 pre-miRNAs, 320 miRNAs and 2968 piRNAs in human and mouse. Brain_C: healthy (hum
and Brain_low-MNase: adult mouse brain sample treated with high or low, respectively, cogenes being predicted by all three methods (Supplemental Table 5).
We next used the bioinformatics resources of the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID) [29] to analyze the
potential target genes for enrichment of Gene Ontology (GO) terms and
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (Fig. 1).
The most enriched GO cellular component was “synapse”, and the
most enriched KEGGpathwaywas “neurotrophin signaling”, suggestingMus musculus
-5Y Brain_high-MNase Brain_low-MNase total
179 197 455
126 148 320
1649 1419 2968
use reference genomes, respectively, to obtain the genomic coordinates of binding sites
nomic coordinates of TDP-43 binding sites identiﬁed potential TDP-43 binding sites in
an) brain; Brain_F: FTLD brain; hES: human embryonic stem cells; Brain_high-MNase
ncentration of micrococcal nuclease (MNase).
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ation and development.
2.3. miR-NID1, a novel intronic miRNA found in human and mouse
We found that the genomic loci of 36 and 143 TDP-43 binding
miRNAs in human andmouse, respectively, lay in the introns of protein
coding or non-coding genes (Supplemental Table 2). Furthermore, we
collected 1998 human predicted novel miRNAs from ENSEMBL data-
base, and found TDP-43 binding sites in 206 predicted novel miRNAs,
106 of these being processed from introns of other genes, including
neural activities associated genes, such as DSCAM (NM_001389),
RIMS2 (NM_001100117) and NRXN1 (NM_001135659) (Supplemen-
tal Table 6). We found a potential binding site of TDP-43 on chromo-
some 2, which was located antisense to the ﬁfth intron of the human
neurexin 1 (NRXN1). This indicated that the locus around the binding
site might be transcribed, and TDP-43 might bind to the transcript.
We didn't ﬁnd any transcript transcribed from this locus, but we
found a predicted pre-miRNA (ENST00000401372) in the ENSEMBL
database [30]. This pre-miRNA is predicted to be processed from
the ﬁfth intron of NRXN1. The binding site of TDP-43 was antisense
to the pre-miRNA (Fig. 2A). Secondary structure of this pre-miRNA
was shown (Fig. 2B). Conservation sequence analysis was carried
out, indicating that the predicted pre-miRNA is only found in the
intron of human NRXN1 (Fig. 2C).
The exon–intron structure of human NRXN1 is conserved in mouse
and rat, but the intronic sequence is not. RT-PCR and qRT-PCR assays
showed that a miRNA (henceforth labeled miR-NID1, NRXN1 intron
derived miRNA) was expressed in variable degree in the human
and mouse tissue samples and cell lines (Fig. 3A). Northern blots
against the sequence of miR-NID1 on RNA from three cell lines,
N2a, SH-SY-5Y-C and SH-SY-5Y-W (the latter two being SH-SY-5Y
cells from two different labs), conﬁrmed the differential expression of
miR-NID1 observed in the RT-PCR results, in that both pre-mir-NID1
and miR-NID1 were detected in SY-5Y-C and N2a, but not in SY-5Y-W
cells (Fig. 3B). Since the sequence of miR-NID1 is not found in theFig. 2. Predicted pre-miRNA ENST00000401372. A. Genomic location of TDP-43 binding site,
of them are located on the minus (−) strand of the human chromosome 2. CLIP-seq read fr
mosome 2. B. Hairpin structure of ENST00000401372 as predicted by mfold. The minimum fr
among human, mouse and rat. E4, E6, E8 and E9 of human NRXN1 are conserved in mouseintrons of mouse Nrxn1, miR-NID1 we detected in mouse samples
might be transcribed and processed from other genomic loci. We
aligned the sequence of miR-NID1 to mouse reference genome,
obtained the ﬂanking sequences (~90 nt) of loci that exactly matched
miR-NID1 and predicted their secondary structures. We found 4
pre-miR-NID1 candidates that could fold into stem-loop structures
and located in the introns of protein-coding genes (Supplemental
Table 7).
Next, we cloned the human ENST00000401372 in the pEGFP-C2
vector and transfected it into HEK293T cells (Fig. 3C). Endogenous ex-
pression level of miR-NID1 was low in HEK293T cells. And we observed
a signiﬁcantly (p b 0.01) increased expression level of miR-NID1 in
transfected cells compared to controls (Fig. 3D). Then we knocked
downdicer in theHEK293T cells (Supplemental Fig. 2) and cotransfected
the cells with the pre-mir-NID1 (pEGFP-ENST00000401372) or empty
plasmid. Northern blot analysis indicated that ENST00000401372 could
be processed into miR-NID1 by dicer (Fig. 3E). Expression level of
miR-NID1was signiﬁcantly (p b 0.01) decreased after dicer knockdown,
whichwas in a similar fashion to let-7d (Fig. 3F). But after TDP-43 knock-
down, we did not observed obvious expression change of miR-NID1
(Supplemental Fig. 3). 5′- and 3′- RACE assays determined the human
miR-NID1 as a 21-nt miRNA with the sequence 5′-CACACACACACAC
ACACGUAU-3′. In order to determine the subcellular localization of
miR-NID1, we fractionated SY-5Y-C cells into nuclear and cytoplasmic
parts, and found that miR-NID1 was signiﬁcantly (p b 0.01) enriched
in the nuclei (Fig. 3G).
We predicted the target genes of miR-NID1 using three methods:
miRanda [9], PITA [10] and TargetScan [11], and got 295 potential tar-
get genes predicted by all three methods (Supplemental Table 8). GO
term and KEGG pathway enrichment analysis on the target genes
gave “synaptic vesicle” as the most enriched GO cellular component
term and “ Hedgehog signaling” as the most enriched KEGG pathway
(Supplemental Fig. 4). Two candidate target genes, SLC6A19 and
NACC2, were chosen for further validations. After overexpression of
miR-NID1 in HEK293T cells, we found that expressions of SLC6A19
and NACC2 were signiﬁcantly (p b 0.01) reduced (Fig. 3H). Then weENST00000401372 and NRXN1. ENST00000401372 is in the intron 5 of NRXN1, and both
om embryonic stem cells is shown in bold and mapped to the plus (+) strand of chro-
ee energy is shown. The miR-NID1 sequence is shown in bold. C. Conservation of NRXN1
and rat. The arrow points at the location of miR-NID1.
Fig. 3. Expression and subcellular localization of miR-NID1 in human and mouse sam-
ples. Cell lines SH-SY-5Y-C and -Wwere obtained from the labs of Prof. Runsheng Chen
and Prof. Jane Y. Wu, respectively. ICR E18 and ICR adult indicate mouse brain samples
of the respective stages. (A) RT-PCR (upper panel), qRT-PCR (lower panel; normalized
to human brain) and (B) Northern blot. C. Overexpression of miR-NID1 from the
pre-mir-NID1 vector assayed by RT-PCR in HEK293T cells. EGFP mRNA was used as
loading control. Two replicates (1&2) are shown. Quantiﬁcation of miR-NID1 levels
after transfections of the pre-mir-NID1 plasmids is shown (D). E. miR-NID1 is
processed from pre-mir-NID1 (ENST00000401372) by dicer. Dicer siRNAs or control
siRNAs were transfected into HEK293T cells, and 48 h later the pre-mir-NID1 or
empty vector (ctrl) was also transfected into the cells. After another 48 h, RNAs smaller
than 200 nt were isolated from the cells and subjected to Northern blot. 5S rRNA was
used as loading control. F. Relative expression levels of miR-NID1 and let-7d after dicer
knockdown. G. qRT-PCR showing the nuclear enrichment of miR-NID1 in SY-5Y-C cells.
NE, nuclear extracts; CE, cytoplasmic extracts. H. Endogenous expression levels of
SLC6A19 and NACC2 are inhibited by miR-NID1 in HEK293T cells. Overexpression of
miR-NID1 inhibited the expression of SLC6A19 and NACC2 relative to control mimic.
I. SLC6A19 is a direct target of miR-NID1. The 3′UTR reporter constructs of SLC6A19
and NACC2 were transfected with control mimic or miR-NID1 mimic into HEK293T
cells. Luciferase activities were measured 24 h after transfection. (n = 3; means ± SEM;
** = p b 0.05; *** = p b 0.01.)
Fig. 4. Association between miR-NID1 and TDP-43. A. Nucleocytoplasmic fractionation
and RNA immunoprecipitation (RIP) followed by RT-PCR in SY-5Y-C cells. About one
percent of the cytoplasmic extracts (CE) and nuclear extracts (NE) were used for
input, respectively. Rabbit IgG served as negative control. NTC, no template control.
TDP-43 was as a positive control. B. Electrophoretic mobility shift assays (EMSA)
were performed using recombinant His-tagged TDP-43 and biotin labeled miRNAs.
miR-NID1 (left), a sequence fully complementary to miR-NID1 (as-miR-NID1; middle),
miR-663 (right). +, with His-TDP-43 added; −, no His-TDP-43 added.
79Z. Fan et al. / Genomics 103 (2014) 76–82cotransfected miRNA mimic and 3′UTR luciferase reporter constructs
in HEK293T cells, and measured the luciferase activities 24 h later.
The dual-luciferase assay showed that SLC6A19 was a direct target
of miR-NID1 (Fig. 3I).2.4. miR-NID1 binds directly to TDP-43
To examine the interaction between miR-NID1 and TDP-43, we
applied nucleocytoplasmic fractionation and RNA immunoprecipita-
tion (RIP) assays to SY-5Y-C cells and detected endogenous TDP-43
associated with miR-NID1 in both cytoplasm and nuclei (Fig. 4A).
TDP-43, which binds its own mRNA, is as a positive control [31].
To further clarify whether the association between miR-NID1 and
TDP-43 is direct or indirect, we performed an electrophoretic mobili-
ty shift assay (EMSA) (Fig. 4B). Puriﬁed recombinant His-tagged
TDP-43 (His-TDP-43) was incubated with biotin-labeled miR-NID1.
The result showed a direct binding between miR-NID1 and TDP-43.
A sequence fully complementary to miR-NID1 (as-miR-NID1), which
could not bind TDP-43, is as a negative control. miR-663, a positive
control, was reported to directly bind TDP-43 [25].2.5. miR-NID1 represses the expression of NRXN1 through TDP-43
To investigate whether miR-NID1 might affect the expression of its
host gene, we assayed the endogenous expression levels of NRXN1
and NRXN1α in human and mouse samples (Fig. 5A). The expression
level of NRXN1 contains NRXN1α and NRXN1β levels, while NRXN1α
only represents level of NRXN1α. Inmost of the human samples (except
U87 and human lung), we observed that expression levels of NRXN1
and NRXN1α appear to be negatively correlated with the levels of
miR-NID1 (e.g. compare, cell line SY-5Y-C and SY-5Y-W, i.e., Figs. 3A
and 5A lanes 2 and 3). Experiments on HEK293T cells validated the
negative correlation between miR-NID1 and NRXN1 (Fig. 5B). We
overexpressed miR-NID1 using the pre-mir-NID1 vector and knocked
down its expression by miR-NID1 inhibitor (Fig. 5B lanes 5–8). To
examine whether TDP-43 was involved in the repression of NRXN1
expression, we knocked down TDP-43 by RNAi or overexpressed it by
the pCS2-TDP plasmid (Fig. 5B lanes 1–4). The results showed that
when either TDP-43 or miR-NID1 was depleted, the level of NRXN1
was signiﬁcantly (p b 0.01) increased (Fig. 5B lanes 2 and 8). The
expression level of NRXN1 decreased slightly after overexpression of
TDP-43 or miR-NID1 (Fig. 5B lanes 4 and 6).
Fig. 5. TDP-43 andmiR-NID1 inhibited NRXN1 expression. A. Endogenous NRXN1 expres-
sion levels in human andmouse samples by RT-PCR. NRXN1, expression levels of NRXN1α
andNRXN1β;β-actin, as a loading control. B. Analysis ofNRXN1expression inHEK293T cells.
RT-PCR (upper panel) and qRT-PCR (lower panel; n = 3; means ± SEM; *** =p b 0.01).
Plasmids (pCS2, pCS2-TDP, pEGFP-C2 and pre-mir-NID1) were transfected into HEK293T
cells for 24 h, and RNA oligos (siRNAs and miRNA inhibitors) were transfected for 48 h.
NTC, no template control; β-actin, as a loading control.
Fig. 6.Model of the repression of NRXN1 bymiR-NID1 associatedwith TDP-43.miR-NID1
precursor is processed fromNRXN1 pre-mRNA or an independent pri-mir-NID1 transcript
in nucleus, and cleaves into miR-NID1 by dicer in cytoplasm. Then AGO-miR-NID1 com-
plex binds to TDP-43 in cytoplasm and is transported into the nucleus. miR-NID1 targeted
promoter regions of NRXN1 to induce transcriptional silencing of NRXN1. TGS, transcrip-
tional gene silencing.
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In this study, we identiﬁed potential TDP-43 binding sRNAs on a
transcriptome-wide scale in human and mouse samples. The study
further found a novel intronic miRNA, miR-NID1, with 8 CA repeats,
which appears to regulate the expression of its host gene, NRXN1.
CA repeats are the most common class of microsatellite DNA in the
human genome and have been reported to regulate RNA stability
and splicing [32,33].
We predicted the target sites of miR-NID1 in the mRNA of NRXN1
using miRanda, and got no hits in either the untranslated region
(UTR) or the coding sequence (CDS). In the promoter region of
NRXN1, we found a potential target site of miR-NID1 predicted by
PITA [10] (Fig. 6). Promoter targeting miRNAs have been shown to
induce gene expression activation or transcriptional gene silencing
(TGS) [34]. Regulation of NRXN1 through interaction with miR-NID1
is a previously uncharacterized function of TDP-43, and a model of
this function is sketched in Fig. 6. Pre-mir-NID1 is processed from
the human NRXN1 pre-mRNA or an independent primary miR-NID1
transcript in nucleus, and appears to be cleaved into miR-NID1 by
dicer in cytoplasm. TDP-43 shuttles between the nucleus and cyto-
plasm, and has been reported to involve in RNA transport and associ-
ate with AGO2 [15,24], thus, AGO-miR-NID1 complex might bind to
TDP-43 in cytoplasm and then be transported into the nucleus to
bind the promoter region of NRXN1 to mediate TGS. But the detailed
mechanism for the inhibition of NRXN1 expression still remains to
be clariﬁed in further studies.
Mutations in the gene that encodes TDP-43 have been found in spo-
radic or familial ALS cases [35]. Reported data increasingly show that al-
tered levels of the TDP-43 protein are associatedwith neurodegenerative
disorders, but the detailedmechanismbywhich these occur still remains
to be elucidated. Previous reports have shown that TDP-43 regulatesmiRNA biogenesis and associates with miR-558, miR-574 and miR-663
[24,25]. In our data, we also observed interactions between TDP-43 and
these three miRNAs (Supplemental Table 2). miRNAs and piRNAs have
attracted much attention in the past several years, and a number of bio-
logical functions associatedwith these sRNAshave beendiscovered. High
levels of piRNA transcriptions have been detected in the rat brain [36],
and our study indicated several thousand piRNAs as potential TDP-43
binding RNAs in the mouse brain. Thus, TDP-43 might participate in a
large number of biological processes through interaction with and/or
regulation of miRNAs and piRNAs.
Biological annotations of TDP-43 binding miRNAs suggested the
involvement of TDP-43 in neural activities. The TDP-43 binding sites
in the intron of NRXN1 indicate that the expression of NRXN1 might
be regulated by TDP-43. Neurexins are proteins that function as cell
adhesion molecules and receptors in the vertebrate nervous system,
modulating synaptic development including calcium signaling, het-
erogeneous cell-to-cell adhesion and synaptogenesis [37,38]. Mam-
mals have three neurexin genes, NRXN1, NRXN2 and NRXN3. Each of
the three genes has two promoters that regulate the transcription of
the loci into either long α-neurexins or short β-neurexins [39]. Mul-
tiple isoforms from NRXN1α and NRXN1β have been identiﬁed, yet
their precise functions are not fully known. Disruptions or mutations
of NRXN1 have been reported to associate with autistic spectrum
disorder (ASD), mental retardation, and schizophrenia [40]. NRXN1
knockout mice have pervasive behavioral abnormalities and cognitive
disorder [41]. The novel miRNA, miR-NID1, identiﬁed in this study is
in the ﬁfth intron of NRXN1 and directly binds to TDP-43 and our
results suggest that both miR-NID1 and TDP-43 are involved in the
repression of NRXN1. As such, our results support previously reports
[22,42] on the association of TDP-43 with neurodevelopment.4. Materials and methods
4.1. CLIP-seq data analysis
The CLIP-seq data were obtained from the ArrayExpress archive
[43]. Genome coordinates of human pre-miRNAs and miRNAs were
obtained from miRBase Release 19 [44]. The sequences of piRNAs in
human and mouse were downloaded from the piRNA cluster data-
base [45]. Genomic positions of binding sites were presented in the
Browser Extensible Data (BED) format. BEDTools were employed to
search for binding sites of TDP-43 in sRNAs [27].
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Threemethods,miRanda [9], PITA [10] and TargetScan [11]were ap-
plied to predict target genes of TDP-43 binding miRNAs. The minimum
free energy threshold used in miRanda was−40 kcal/mol. The thresh-
old of ΔΔG score in PITA was −17. In TargetScan, only conserved
miRNA target sites across most mammals were selected. Enrichment
analysis for GO terms and KEGG pathways was carried out using the
DAVID bioinformatics resources [29].
4.3. Cells, human and mouse samples
U87, SH-SY-5Y-W, N2a andHT22 cells were obtained fromProf. Jane
Y. Wu's lab at the Institute of Biophysics, Chinese Academy of Sciences.
SH-SY-5Y-C and HEK293T cells were purchased from the Institute of
Basic Medical Sciences of the Chinese Academy of Medical Sciences.
The cells were cultured in DMEM (Gibco) media supplemented with
10% fetal bovine serum (Gibco) at 37 °C with 5% CO2. Plasmids
and RNA oligos (miRNA mimics, miRNA inhibitors or siRNAs ordered
fromGenePharma)were transfected into cells using lipofectamine2000
(Invitrogen) according to the productmanual. ICRmicewere purchased
from the Animal Center of the Chinese Academy of Medical Science,
Beijing. Brains of ICRmicewere dissected and subjected to total RNA ex-
tractions. Human lung, thymus, retina and brain tissues were obtained
as described by Guo et al. [46] in compliance with the US National Insti-
tutes of Health (NIH) and institutional guidelines. All samples were
lysed in Trizol (Invitrogen), adding chloroform (Applichem) for phase
separation and isopropyl alcohol (Sigma) for RNA precipitation, then
washed twice with 75% ethanol (Sigma) and dissolved in nuclease
free water (Ambion). Extracted total RNA was treated with DNase I
(Roche), quantiﬁed by UV absorbance spectroscopy and checked on
1% formaldehyde-agarose gels for quality control.
4.4. RT-PCR and quantitative RT-PCR (qRT-PCR)
For the detection of miR-NID1, a modiﬁed stem-loop RT-PCR proto-
col [47] was used. Two-step RT-PCR was performed using the Super-
Script III First-Strand Synthesis System (Invitrogen). One microliter RT
product was used for 25 μl PCR reaction. RT-PCRs for other RNAs
were performed using the TransScript II One-Step RT-PCR SuperMix
(Transgen) according to the manufacturer's instructions. RT-PCR prod-
ucts were checked on 6% nondenaturing polyacrylamide (PAGE) or 2%
agarose gels. To quantify the expression levels of miRNAs, we used the
NCode VILO miRNA qRT-PCR kits (Invitrogen) and normalized to 5S
rRNA and U6. For measuring mRNAs, TransScript II Green One-Step
qRT-PCR SuperMix (Transgen) was chosen, normalizing with β-actin
and GAPDH. Primer sequences are listed in Supplemental Table 9.
4.5. Northern blot, 5′- and 3′- RACE
Northern blot and RACE were carried out as described previously
[48] with a fewmodiﬁcations. RNAs of less than 200 nt were enriched
by the NucleoSpin miRNA (MACHEREY-NAGEL) kit, loaded onto 12%
denaturing PAGE, transferred to a nylon membrane (Hybond-N+;
GE Healthcare), and hybridized with DIG-labeled RNA probes at
37 °C. For the RACE experiments, 3′ and 5′ adapter ligations were
performed on total RNA from SH-SY-5Y-C cells, and the ligated prod-
ucts were subjected to RT-PCR. The PCR products were inserted into
the pEASY-T5 Zero plasmid (Transgen) and sequenced at Beijing
Genomics Institute. Primers for the 5′- and 3′- RACE assays are also
listed in Supplemental Table 9.
4.6. Dual-luciferase reporter assay
The 3′UTR sequences of SLC6A19 and NACC2 were ampliﬁed and
inserted into the psicheck2 (Promega) plasmid. HEK293T cells werecotransfected with 3′UTR luciferase reporter constructs and control
or miR-NID1 mimics in 24-well plates. And the luciferase activities
were measured according to the manual of the dual-luciferase reporter
assay system (Promega).
4.7. Nucleocytoplasmic fractionation and RNA immunoprecipitation (RIP)
Cells were harvested and lysed in cytoplasmic buffer (10 mM
Tris–HCl (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.5 mM
PMSF, 1× Protease Inhibitor Cocktail (Sigma), and 0.1 U/ml of RNasin
(Promega)) for 10 min on ice. The cytoplasmic fraction was collected
after centrifugation at 4 °C, 13,300 rpm for 10 s. The pellet was added
ice-cold nuclear lysis buffer (50 mM Tris–HCl (pH 7.4), 450 mMNaCl,
1% NP-40, 20% glycerol, 2 mM DTT, 1 mM PMSF, 1× Phosphatase
Inhibitor Cocktail (Sigma), 1× Protease Inhibitor Cocktail (Sigma),
and 0.1 U/ml of RNasin (Promega)) , shaken vigorously for 15 s, rest-
ed 10 min on ice, followed by a second shake and centrifuged at 4 °C,
13,300 rpm for 30 min. The nuclear fraction was collected as the
supernatant. For each RIP experiment, both the cytoplasmic and
nuclear fractions were split into three parts for input, the negative
control (IgG) and IP (anti-TDP-43), respectively. Antibody against
TDP-43 (Abcam, IP grade) or puriﬁed rabbit IgG (Millipore) was
added to the lysate with gentle rotation at 4 °C for 1 h. Protein A
beads (Millipore) were added and incubated for another 3 h at 4 °C
with gentle rotation. Beads were collected at 4 °C, 2000 rpm for
2 min, washed for ﬁve times and resuspended in 1 ml Trizol for
RNA isolation and RT-PCR assay.
4.8. Electrophoretic mobility shift assay (EMSA)
EMSAs were carried out as described previously [24] with some
changes. Full-length TDP-43 labeled with a 6 × His tag at the
C-terminus was constructed using pEASY-E2 expression kit (Transgen).
Recombinant TDP-43 was incubated with biotinylated miRNAs and the
motility shift assayed using the LightShift Chemiluminescent RNA
EMSA Kit (Thermo) as described by the manufacturer.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2013.06.006.
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